Corneal latency and transmission of herpes simplex virus-1

ISSN： 1746-0794

Source： Future Virology, Vol.6, Iss.1, 2011-01, pp. : 101-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oncotarget Strategies For Herpes Simplex Virus-1

Current Gene Therapy, Vol. 16, Iss. 2, 2016-04 ,pp. : 130-143

Bentham Science Publishers

Access to resources Recommend Favorite

Current treatment options to prevent perinatal transmission of herpes simplex virus

By Leung Daniel T Sacks Stephen L

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1809-1819

Informa Healthcare

Access to resources Recommend Favorite

Oncolytic Herpes Simplex Virus Type 1 and Host Immune Responses

Current Cancer Drug Targets, Vol. 7, Iss. 2, 2007-03 ,pp. : 149-155

Bentham Science Publishers

Access to resources Recommend Favorite

Piroxicam inhibits herpes simplex virus type 1 infection in vitro

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 5, 2015-01 ,pp. : 331-336

Govi-Verlag

Access to resources Recommend Favorite

Host responses to herpes simplex virus and herpes simplex virus vectors

By Hukkanen Veijo Paavilainen Henrik Mattila Riikka K

Future Virology, Vol. 5, Iss. 4, 2010-07 ,pp. : 493-512

Future Medicine

Access to resources Recommend Favorite